Dechra Pharmaceuticals Plc (DPH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2018 | 06-2017 | 06-2016 | 06-2015 | 06-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,700 | 61,200 | 39,142 | 45,948 | 26,773 |
| Marketable Securities | N/A | N/A | 129 | 579 | N/A |
| Inventories | 86,600 | 56,507 | 54,375 | 31,744 | 29,673 |
| Other current assets | 81,600 | 67,269 | 68,809 | 30,353 | 29,888 |
| TOTAL | $247,900 | $184,976 | $162,455 | $108,624 | $86,334 |
| Non-Current Assets | |||||
| PPE Net | 45,300 | 45,197 | 37,718 | 16,822 | 18,258 |
| Intangibles | 709,800 | 396,262 | 360,381 | 166,684 | 196,182 |
| Other Non-Current Assets | 14,300 | 11,634 | 197 | 0 | 0 |
| TOTAL | $769,400 | $453,093 | $398,296 | $183,506 | $214,440 |
| Total Assets | $1,017,300 | $638,069 | $560,751 | $292,130 | $300,774 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,200 | 965 | 1,648 | 0 | 0 |
| Accounts payable and accrued liabilities | 33,000 | 21,433 | 24,326 | 10,370 | 12,867 |
| Other current liabilities | 8,800 | 1,617 | 467 | 4,417 | 1,784 |
| TOTAL | $91,600 | $66,411 | $66,256 | $44,109 | $35,715 |
| Non-Current Liabilities | |||||
| Long Term Debt | 289,900 | 180,178 | 154,093 | 32,519 | 31,653 |
| Other Non-Current Liabilities | 33,800 | 37,999 | 8,240 | 4,723 | 7,095 |
| TOTAL | $420,700 | $269,021 | $217,883 | $53,533 | $60,253 |
| Total Liabilities | $512,300 | $335,432 | $284,139 | $97,642 | $95,968 |
| Shareholders' Equity | |||||
| Common Shares | 1,000 | 932 | 927 | 880 | 877 |
| Retained earnings | 125,500 | 107,422 | 93,995 | 94,981 | 87,490 |
| Other shareholders' equity | 19,600 | 20,011 | 7,279 | -25,871 | -7,384 |
| TOTAL | $505,000 | $301,074 | $274,631 | $194,488 | $204,806 |
| Total Liabilities And Equity | $1,017,300 | $636,506 | $558,770 | $292,130 | $300,774 |